- ------------------------------
OMB APPROVAL
- ------------------------------
OMB Number: 3235-0145
Expires: October 31, 1994
Estimated average burden
hours per response.....14.90
- ------------------------------
SCHEDULE 13G
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 and 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. )*
AMARILLO BIOSCIENCES, INC.
--------------------------
(Name of Issuer)
Common Stock, par value $.01 per share
--------------------------------------
(Title of Class of Securities)
02301P106
---------
(CUSIP Number)
Check the following box if a fee is being paid with this statement [X]. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
* The remainder of this cover page should be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).
page 1 of 5 pages
<PAGE>
SCHEDULE 13G
CUSIP No. 02301P106 Page 2 of 5 Pages
---------
1 NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE
PERSONS
Hayashibara Biochemical Laboratories, Inc.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)[ ] (b)[ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OR ORGANIZATION
Japan
5 NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH SOLE
VOTING POWER
1,232,856
6 NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH SHARED
VOTING POWER
None
7 NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH SOLE
DISPOSITIVE POWER
1,232,856
8 NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH SHARED
DISPOSITIVE POWER
None
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,232,856
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
24.1%
12 TYPE OF REPORTING PERSON*
CO
*SEE INSTRUCTION BEFORE FILLING OUT!
page 2 of 5 pages
<PAGE>
ITEM 1(A). NAME OF ISSUER:
Amarillo Biosciences, Inc.
ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
800 West 9th Avenue
Amarillo, Texas 79101
ITEM 2(A). NAME OF PERSON FILING:
This statement is being filed by Hayashibara Biochemical Laboratories, Inc., a
Japanese corporation ("HBL"). HBL is making the filing because it owns of record
the shares of Common Stock, par value $.01 per share, of Amarillo Biosciences,
Inc. reported as beneficially owned by it.
ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR, IF NONE, RESIDENCE:
The principal business office of HBL is 2-3, Shimoishii 1-chome, Okayama 700,
Japan.
ITEM 2(C). CITIZENSHIP:
HBL is a Japanese corporation.
ITEM 2(D). TITLE OF CLASS OF SECURITIES:
Common Stock, par value $.01 per share, of Amarillo Biosciences, Inc. ("Common
Stock")
ITEM 2(E). CUSIP NUMBER:
02301P106
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR
13D-2(B), CHECK WHETHER THE PERSON IS:
Not applicable
ITEM 4. OWNERSHIP:
(a) Amount Beneficially Owned:
1,232,856 shares
(b) Percent of Class:
24.1%
page 3 of 5 pages
<PAGE>
(c) Number of shares as to which such person has:
(i) sole power to vote or direct the vote: 1,232,856
(ii) shared power to vote or direct the vote: None
(iii) sole power to dispose or direct the disposition of: 1,232,856
(iv) shared power to dispose or direct the disposition of: None
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OR A CLASS.
If this statement is being filed to report the fact that as of
the date hereof, the reporting person has ceased to be the beneficial owner of
more than five percent of the class of securities, check the following. [ ]
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
Not applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Not applicable
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable.
ITEM 10. CERTIFICATION.
Not applicable.
page 4 of 5 pages
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: September 5, 1996 HAYASHIBARA BIOCHEMICAL
LABORATORIES, INC.
By /s/ Katsuaki Hayashibara
----------------------------
Name: Katsuaki Hayashibara
Title: Director of Research and
Development
page 5 of 5 pages
